Indraprastha Medical Corporation Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

Indraprastha Medical Corporation at Rs 376.9 is a pharma and healthcare company whose share price target of Rs 385 for 2027 represents approximately 2 percent upside from the current market price. The Indraprastha Medical Corporation share price target rises to Rs 440 by 2028 and Rs 585 by 2030, implying a 4-year upside of approximately 55 percent from August 2026 levels. FY26 EPS of ₹17.6 growing approximately15% a year, capitalised at approximately19x forward earnings; growth tapers to approximately12% further out..

The targets are derived from the analyst consensus and forward earnings model based on FY26 financials. This article covers the Indraprastha Medical Corporation share price target 2027, 2028, and 2030 as of August 2026 to help investors evaluate the long-term investment case.

Click Here – Get Free Investment Predictions

Indraprastha Medical Corporation Company Overview

Metric	Details
NSE Ticker	INDRAMEDCO
Sector	Pharma and Healthcare
CMP (07 Aug 2026)	Rs 376.9
Market Cap	Rs 3455 Cr
FY26 EPS	Rs 17.6 (15% annual growth)
Indraprastha Medical Corporation Share Price Target 2027	Rs 385 (+2%)
Indraprastha Medical Corporation Share Price Target 2028	Rs 440 (+17%)
Indraprastha Medical Corporation Share Price Target 2030	Rs 585 (+55%)
Bull Case 2030	Rs 749
Bear Case 2030	Rs 439

What most investors miss: Unique JV structure: Apollo Hospitals Enterprise (22%) and Delhi State Government (26%) are joint promoters; operates the well-known Apollo-brand Indraprastha hospital in Delhi (718 beds) plus a Noida facility

FY26 EPS of ₹17. 6 growing approximately15% a year, capitalised at approximately19x forward earnings; growth tapers to approximately12% further out. The share price target of Rs 385 for 2027 and Rs 585 for 2030 reflect this earnings trajectory.

Why Is the Indraprastha Medical Corporation Share Price Target Set at Rs 385 for 2027

Domestic Branded Formulations Revenue Growth

This is the primary driver of the Indraprastha Medical Corporation share price target for 2027 and 2030. FY26 EPS of ₹17.6 growing approximately15% a year, capitalised at approximately19x forward earnings; growth tapers to approximately12% further out.. Investors tracking this metric quarterly will have the earliest signal of whether the Indraprastha Medical Corporation share price target timeline is on track.

Export Markets and Regulatory Compliance Track Record

The Indraprastha Medical Corporation share price target of Rs 385 for 2027, rising to Rs 585 by 2030, assumes this factor remains intact and compounds through the forecast period. Any deterioration in this dimension would be the earliest warning for the Indraprastha Medical Corporation share price target thesis.

Product Pipeline and New Launch Capability

This structural factor underpins the long-term Indraprastha Medical Corporation share price target of Rs 585 by 2030 beyond the near-term 2027 milestone. Its persistence through economic cycles is what differentiates this investment from a purely cyclical trading position.

Manufacturing Scale and Cost Efficiency

For the Indraprastha Medical Corporation share price target to materialise, this factor must continue to hold and improve through FY27 to FY31. It provides the margin of safety for the Rs 440 target in 2028 when earnings quality is most clearly visible.

India's Healthcare Spending Growth Is a Structural Tailwind

India's long-term economic growth trajectory creates a secular tailwind for Indraprastha Medical Corporation's business that amplifies the company-specific earnings compounding embedded in the Indraprastha Medical Corporation share price target 2030 of Rs 585 (+55% from CMP Rs 376.9).

Indraprastha Medical Corporation Share Price Targets 2027, 2028 and 2030

Indraprastha Medical Corporation Share Price Target 2027: Rs 385

The Indraprastha Medical Corporation share price target 2027 is Rs 385, representing approximately 2 percent upside from CMP Rs 376.9. FY26 EPS of ₹17.6 growing approximately15% a year, capitalised at approximately19x forward earnings; growth tapers to approximately12% further out.. The primary catalyst for achieving the 2027 target is consistent quarterly earnings delivery that validates the analyst model underpinning the Indraprastha Medical Corporation share price target.

Indraprastha Medical Corporation Share Price Target 2028: Rs 440

The Indraprastha Medical Corporation share price target 2028 is Rs 440, implying approximately 17 percent upside from CMP. By FY29, Indraprastha Medical Corporation should have demonstrated through a complete earnings cycle that the forward growth assumptions are sustainable. This two-year validation of the Indraprastha Medical Corporation share price target thesis typically triggers institutional re-rating toward the Rs 440 level.

Indraprastha Medical Corporation Share Price Target 2030: Rs 585

The Indraprastha Medical Corporation share price target 2030 is Rs 585, implying approximately 55 percent upside from CMP and a 4-year CAGR of approximately 12 percent. By FY31, Indraprastha Medical Corporation should be operating as a mature business with a track record of consistent compounding, justifying the target multiple. Always verify data at NSE and BSE before acting on analyst price targets.

Bull Case and Bear Case for Indraprastha Medical Corporation Share Price Target 2030

Bull Case: Rs 749

The bull case Indraprastha Medical Corporation share price target of Rs 749 by 2030 requires earnings growth to exceed the base case projection and the market to re-rate the stock to a higher-than-consensus multiple. Favourable macro conditions, new product or geographic expansion wins, and sustained margin improvement would drive this upside scenario.

Bear Case: Rs 439

The bear case Indraprastha Medical Corporation share price target of Rs 439 by 2030 applies if earnings growth disappoints relative to analyst expectations, competitive pressure intensifies, or a macro slowdown compresses the sector multiple. Even in this scenario, the downside reflects a more conservative earnings assumption rather than a fundamental business failure.

Scenario	Target 2030	Return
Bull Case	Rs 749	+99%
Base Case	Rs 585	+55%
Bear Case	Rs 439	+16%

Key Risks to the Indraprastha Medical Corporation Share Price Target

USFDA Compliance and Inspection Risk

Any regulatory action on Indraprastha Medical Corporation's manufacturing facilities could delay product launches and reduce the Indraprastha Medical Corporation share price target earnings.

Currency Risk on Export Revenue

INR appreciation against USD and EUR reduces the INR value of Indraprastha Medical Corporation's international revenues and the Indraprastha Medical Corporation share price target EPS.

Generic Pricing Pressure in Export Markets

Intensifying competition in US and European generic markets compresses pricing and the Indraprastha Medical Corporation share price target margin assumptions.

Clinical and Approval Timeline Risk

Delays in pipeline product approvals would push revenue ramp-up beyond the Indraprastha Medical Corporation share price target timeline.

How to Invest in Indraprastha Medical Corporation

Use the Univest Screener to track Indraprastha Medical Corporation's quarterly earnings, key sector-specific metrics, and analyst upgrades in real time. To purchase shares, open a demat account with any SEBI-registered broker and search for NSE ticker INDRAMEDCO. Review the quarterly earnings data and the risk factors outlined in this article before committing capital. Build positions gradually and align the holding period to the Indraprastha Medical Corporation share price target 2030 timeline of approximately 4 years. Consult a SEBI-registered financial advisor before investing.

Use the Univest Screener to Track This Stock Live

Conclusion

The Indraprastha Medical Corporation share price target of Rs 385 for 2027, Rs 440 for 2028, and Rs 585 for 2030 reflects analyst consensus earnings compounding in the pharma and healthcare sector. The 4-year upside of approximately 55 percent from CMP Rs 376.9 assumes the business delivers on the growth drivers outlined above and maintains the valuation multiple consistent with sector peers. Always verify financial data at NSE India and BSE before making any investment decision.

Download the Univest iOS App or Univest Android App to track Indraprastha Medical Corporation share price live and get daily stock recommendations.

Frequently Asked Questions on Indraprastha Medical Corporation Share Price Target 2027 2028 and 2030

What is the Indraprastha Medical Corporation share price target for 2027?

Ans. The Indraprastha Medical Corporation share price target for 2027 is Rs 385, representing approximately 2 percent upside from CMP Rs 376.9 as of August 2026. Please verify all data at NSE India before investing.

What is the Indraprastha Medical Corporation share price target for 2030?

Ans. The Indraprastha Medical Corporation share price target for 2030 is Rs 585, implying approximately 55 percent upside from CMP Rs 376.9. This reflects the analyst consensus extrapolated at the projected growth rate. These are estimates, not guaranteed returns.

What is the Indraprastha Medical Corporation share price target for 2028?

Ans. The Indraprastha Medical Corporation share price target for 2028 is Rs 440, implying approximately 17 percent upside from CMP. By 2028, two full years of earnings delivery should validate the analyst model and support a re-rating toward this level.

Is Indraprastha Medical Corporation a good long-term investment?

Ans. Indraprastha Medical Corporation has a defined analyst projection for earnings compounding through FY31 in the pharma and healthcare sector. Whether it suits your portfolio depends on your risk appetite, investment horizon, and sector allocation. Consult a SEBI-registered financial advisor before investing.

What are the key risks to the Indraprastha Medical Corporation share price target?

Ans. Key risks include sector-specific headwinds such as usfda compliance and inspection risk, currency risk on export revenue, and broader macro slowdowns. Please review the full risks section in this article before investing.

What is the bull case for Indraprastha Medical Corporation share price by 2030?

Ans. The bull case Indraprastha Medical Corporation share price target for 2030 is Rs 749, requiring earnings growth above the base case and a higher PE multiple. This scenario needs favourable execution and sector conditions. These are analyst projections, not guaranteed returns.

What is Indraprastha Medical Corporation's current market cap?

Ans. Indraprastha Medical Corporation has a market cap of approximately Rs 3455 crore as of August 2026 based on the data available. Verify the current market cap at NSE India or BSE before making investment decisions.

How can I invest in Indraprastha Medical Corporation?

Ans. You can buy Indraprastha Medical Corporation shares through any SEBI-registered broker by searching for NSE ticker INDRAMEDCO. Review the fundamentals and risk factors before investing, and consult a SEBI-registered financial advisor for personalised guidance.